These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20533518)

  • 1. A global view of regulations affecting nanomaterials.
    Hansen SF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):441-9. PubMed ID: 20533518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective.
    Tinkle SS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):88-98. PubMed ID: 20049833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations.
    Fan AM; Alexeeff G
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8646-57. PubMed ID: 21121378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk management of nanomaterials.
    Gwinn MR; Tran L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):130-7. PubMed ID: 20077523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health and safety implications of occupational exposure to engineered nanomaterials.
    Stebounova LV; Morgan H; Grassian VH; Brenner S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):310-21. PubMed ID: 22131295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of research to the responsible and sustainable development of nanotechnologies].
    Iavicoli S; Boccuni F
    G Ital Med Lav Ergon; 2008; 30(3 Suppl):110-4. PubMed ID: 19288800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research strategies for safety evaluation of nanomaterials, part VIII: International efforts to develop risk-based safety evaluations for nanomaterials.
    Thomas K; Aguar P; Kawasaki H; Morris J; Nakanishi J; Savage N
    Toxicol Sci; 2006 Jul; 92(1):23-32. PubMed ID: 16687392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A; Nishimura T; Kanno J
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk characterization for nanotechnology.
    Williams RA; Kulinowski KM; White R; Louis G
    Risk Anal; 2010 Nov; 30(11):1671-9. PubMed ID: 21039703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits.
    Nat Nanotechnol; 2006 Dec; 1(3):151. PubMed ID: 18654169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment of engineered nanomaterials and nanotechnologies--a review.
    Savolainen K; Alenius H; Norppa H; Pylkkänen L; Tuomi T; Kasper G
    Toxicology; 2010 Mar; 269(2-3):92-104. PubMed ID: 20105448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology and human health: risks and benefits.
    Cattaneo AG; Gornati R; Sabbioni E; Chiriva-Internati M; Cobos E; Jenkins MR; Bernardini G
    J Appl Toxicol; 2010 Nov; 30(8):730-44. PubMed ID: 21117037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Organizing the supervision over the turnover of nanomaterials presenting a potential hazard to human health].
    Onishchenko GG
    Gig Sanit; 2011; (2):4-9. PubMed ID: 21604392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C; Berges M; Chaudhry Q; Dusinska M; Fernandes TF; Olsen SI; Nowack B
    Toxicology; 2010 Mar; 269(2-3):160-9. PubMed ID: 20025922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe handling of nanotechnology.
    Maynard AD; Aitken RJ; Butz T; Colvin V; Donaldson K; Oberdörster G; Philbert MA; Ryan J; Seaton A; Stone V; Tinkle SS; Tran L; Walker NJ; Warheit DB
    Nature; 2006 Nov; 444(7117):267-9. PubMed ID: 17108940
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory landscape of nanotechnology and nanoplastics from a global perspective.
    Allan J; Belz S; Hoeveler A; Hugas M; Okuda H; Patri A; Rauscher H; Silva P; Slikker W; Sokull-Kluettgen B; Tong W; Anklam E
    Regul Toxicol Pharmacol; 2021 Jun; 122():104885. PubMed ID: 33617940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.